Kilitch Drugs Announces Board Meeting to Review Q1 FY27 Results
Kilitch Drugs India Ltd has scheduled its Board of Directors meeting to review the unaudited financial results for the quarter ending June 30, 2026. The company confirmed that the meeting will take place on Thursday, August 13, 2026.The board is set to consider and approve the standalone and consolidated Unaudited Financial Results of Kilitch Drugs for the specified quarter.
In addition to the board matter, the company also provided an update regarding the trading window status. The trading window was closed effective July 1, 2026, and will reopen 48 hours after the financial results are disclosed to the Stock Exchanges.
KILITCH Stock Price Movement
As of 10:37 AM, shares of Kilitch Drugs (India) Limited slip by 0.86% in live trading, currently priced at ₹191.86 as the stock trades within an intraday range of ₹189.40 to ₹199.59.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.